Smart & Biggar: Canada’s New Linkage Litigation Scheme


In September 2017, the Government of Canada published their final pharmaceutical regulations, flowing from the CETA, alongside amendments to the Patent Act.

In this article, Smart & Biggar discuss the details and the key provisions of the PMNOC Regulations amendments and the CSP Regulations. They also give insight on the new system’s comparison to the Hatch-Waxman.

Fields marked with an * are required

Enter your details below to view the article

We will process your personal data in order to provide you with the information that you have requested; to share with our sponsors so that they may send you information about their products and services where you have consented to us doing so by ticking the box at the end of this form; and in accordance with our privacy policy

If you decide that you no longer want to receive information about our events and products, you can contact us at any time on Each of our communications about our events and products that we send to you (whether by email, phone, post or SMS) will also include an appropriate and easy way for you to opt out of receiving further communications from us.

If you have any questions about how we will use your personal data, or our privacy policy, please contact